Question 1

What are the potential benefits and risks of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma clinical trial (NCT04998669). Contact the study team or your healthcare provider for specific answers.

Question 2

How does this treatment compare to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma clinical trial (NCT04998669). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like, and how often will I need to come in for visits?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma clinical trial (NCT04998669). Contact the study team or your healthcare provider for specific answers.

Question 4

Are there any specific side effects I should be aware of?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma clinical trial (NCT04998669). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my health be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma clinical trial (NCT04998669). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I do not respond to the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Loncastuximab Tesirine in Combination With Rituximab in Patients With Relapsed or Refractory Follicular Lymphoma clinical trial (NCT04998669). Contact the study team or your healthcare provider for specific answers.

What this study is about